News
MIST
1.320
+7.32%
0.090
Weekly Report: what happened at MIST last week (0421-0425)?
Weekly Report · 2d ago
Weekly Report: what happened at MIST last week (0414-0418)?
Weekly Report · 04/21 09:02
Weekly Report: what happened at MIST last week (0407-0411)?
Weekly Report · 04/14 09:02
Milestone Pharmaceuticals: A Golden Opportunity To Buy On Etripamil's CRL In PSVT
Seeking Alpha · 04/09 14:26
Based on the provided financial report, the title of the article is: "Milestone Pharmaceuticals Inc. (MIST) Annual Report (Form 10-K) for the fiscal year ended December 31, 2024
Press release · 04/07 16:18
Weekly Report: what happened at MIST last week (0331-0404)?
Weekly Report · 04/07 09:02
Stock Picks From Seeking Alpha's March 2025 New Analysts
Seeking Alpha · 04/04 18:30
MIST Stock Falls 66% Following Complete Response Letter for Cardamyst
NASDAQ · 04/02 19:00
Milestone Pharmaceuticals Price Target Cut to $10.00/Share From $25.00 by HC Wainwright & Co.
Dow Jones · 04/01 16:43
Milestone Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 04/01 16:43
HC Wainwright & Co. Maintains Buy on Milestone Pharmaceuticals, Lowers Price Target to $10
Benzinga · 04/01 16:34
Milestone Pharmaceuticals Inc Cut to Hold From Buy by TD Securities
Dow Jones · 04/01 15:45
MILESTONE PHARMACEUTICALS INC <MIST.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $10 FROM $25
Reuters · 04/01 15:33
BUZZ-Milestone Pharma falls after TD Cowen downgrades to "hold", removes PT
Reuters · 04/01 15:06
Milestone Pharmaceuticals price target lowered to $10 from $25 at H.C. Wainwright
TipRanks · 04/01 14:45
MILESTONE PHARMACEUTICALS INC <MIST.O>: TD COWEN CUTS TO HOLD FROM BUY
Reuters · 04/01 12:41
Milestone Pharmaceuticals downgraded to Hold from Buy at TD Cowen
TipRanks · 04/01 12:37
CANADA RESEARCH ROUNDUP-G Mining Ventures, Rogers Communications, Sigma Lithium
Reuters · 04/01 11:33
Milestone Pharmaceuticals (MIST) was downgraded to a Hold Rating at TD Cowen
TipRanks · 04/01 10:26
Weekly Report: what happened at MIST last week (0324-0328)?
Weekly Report · 03/31 09:02
More
Webull provides a variety of real-time MIST stock news. You can receive the latest news about Milestone Pharmaceuticals through multiple platforms. This information may help you make smarter investment decisions.
About MIST
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.